The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Focused Libraries for Epigenetic Drug Discovery: The Importance of Isosteres: Miniperspective
Abstract
Epigenetic drug discovery provides a wealth of opportunities for the discovery of new therapeutics but has been hampered by low hit rates, frequent identification of false-positives, and poor synthetic tractability. A key reason for this is that few screening collections consider the unique requirements of epigenetic targets despite significant medicinal chemistry interest. Here we analyze the suitability of some commercially available screening collections in the context of epigenetic drug discovery, with a particular focus on lysine post-translational modifications, and show that even privileged motifs found in U.S. Food and Drug Administration (FDA)-approved drugs are not present in these collections. We propose that the incorporation of epigenetic bioisosteres should become central in the design of new focused screening collections and highlight some opportunities for the development of synthetic methods which may improve the tractability of hit molecules.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Acetylated lysine drives the interactions, thus providing a starting point for molecular recognition and ligand development using acetylated lysine bio-isosteres [32].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [32]
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
The molecular hallmarks of epigenetic control
Allis, C. D., & Jenuwein, T. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.59 · Cited by 2,809
The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates
Roughley, S. D., & Jordan, A. M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200187y · Cited by 2,725
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Drugging the undruggable RAS: Mission Possible?
Cox, A. D., Fesik, S. W., Kimmelman, A. C., Luo, J., & Der, C. J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4389 · Cited by 1,997
Brown, D. G., & Boström, J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01409 · Cited by 1,964
An operational definition of epigenetics: Figure 1.
Berger, S. L., Kouzarides, T., Shiekhattar, R., & Shilatifard, A. (2009) · Genes & Development · doi:10.1101/gad.1787609 · Cited by 1,884
The medicinal chemist's toolbox for late stage functionalization of drug-like molecules
Cernak, T., Dykstra, K. D., Tyagarajan, S., Vachal, P., & Krska, S. W. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00628g · Cited by 1,743
Cited by
Mao, L., Liu, Y., & Wan, J. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.110784 · Cited by 54
Drug discovery for epigenetics targets
Holdgate, G. A., Bardelle, C., Lanne, A., Read, J. A., O’Donovan, D. H., Smith, J. M., Selmi, N., & Sheppard, R. J. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.10.020 · Cited by 36
Song, S., Zhang, Z., Peng, M., Xia, X., Dong, S., Wang, Y., & Yu, F. (2024) · Organic Chemistry Frontiers · doi:10.1039/d4qo00677a · Cited by 29
Chemoinformatic Characterization of Synthetic Screening Libraries Focused on Epigenetic Targets
Flores‐Padilla, E. A., Juárez‐Mercado, K. E., Naveja, J. J., Kim, T. D., Miranda‐Quintana, R. A., & Medina‐Franco, J. L. (2021) · Molecular Informatics · doi:10.1002/minf.202100285 · Cited by 23
Acetylation: a new target for protein degradation in cancer
Crawford, C. E. W., & Burslem, G. M. (2025) · Trends in Cancer · doi:10.1016/j.trecan.2025.01.013 · Cited by 20
Self-citation
Metadata
- Authors
- Green, A. I., & Burslem, G. M.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Burslem, George M.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-05-27
- Volume
- 64
- Issue
- 11
- Pages
- 7231-7240
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W3164094558
- Cited by
- 21
- References
- 77
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 5
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- epigenetic drug discovery, focused libraries, isosteres, lysine post-translational modifications, hit optimization, privileged structures
- MeSH terms
- Biological Products, Humans, Protein Kinases, Protein Processing, Post-Translational, Small Molecule Libraries, Drug Discovery, Histone Demethylases, Epigenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Focused Libraries for Epigenetic Drug Discovery: The Importance of Isosteres: Miniperspective. https://app.cochat.ai/papers/10.1021/acs.jmedchem.1c00592
- The paper
- Green, A. I., & Burslem, G. M. (2021). Focused Libraries for Epigenetic Drug Discovery: The Importance of Isosteres: Miniperspective. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.1c00592
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.